With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.
CI trades against a final fair-value range of $382.18-$742.98, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
Sweeping legislative changes target PBM spread pricing and rebates, crippling Evernorth's profitability. At the same time, sudden medical cost inflation squeezes traditional insurance margins, limiting the cash available to service Cigna's massive debt load.
Federal legislation permanently bans spread pricing and mandates full rebate pass-throughs across all books of business.
Unanticipated structural increase in utilization rates compresses medical loss ratios beyond historical norms.
Inability to service acquisition-related debt due to sustained margin compression, halting share repurchases.
| Line item | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
|---|---|---|---|---|---|---|
| Revenue | $174.27B | $180.03B+3.3% | $195.19B+8.4% | $244.38B+25.2% | — | +8.8% |
| Gross profit | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — |
| Net income | $5.37B | $6.70B+24.8% | $5.16B-23.0% | $3.43B-33.5% | — | -10.6% |
| EPS (diluted) | — | $21.30 | $17.39 | $12.12 | $22.18 | +1.0% |
| EBITDA | — | — | — | — | — | — |
| R&D | — | — | — | — | — | — |
| SG&A | $13.01B | $13.17B | $14.82B | $14.84B | — | +3.3% |
Cash-flow quality is reflected in the OCFOperating cash flowCash generated from the company's core operations after working-capital changes but before capital expenditures. The first line of the cash-flow statement. / net incomeNet IncomeNet Income is an income-statement line item used to reconcile revenue to operating profit, pre-tax income, net income, or per-share earnings. It should be compared across periods and against peer disclosure conventions., accounting-quality, and ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created. rows above.
Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.
| Deterioration versus the report thesis |
| Medical care ratio (MCR) exceeding internal targets for two consecutive quarters. | Monitor | Deterioration versus the report thesis |
| Key enterprise client losses within the Evernorth segment. | Monitor | Deterioration versus the report thesis |
